Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 17Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 6Glioblastoma 5Triple Negative Breast Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Colorectal Neoplasms 4Recurrence 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Hereditary Sensory and Autonomic Neuropathies 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Thymoma 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pre-menopausal Breast Cancer 1

Interventions

Everolimus 5Alpelisib 4berzosertib 3PX-866 3Letrozole 3Fulvestrant 3Cetuximab 3Topotecan 2NVP-BKM120 2tipifarnib 1sotorasib 1serabelisib 1ribociclib 1pembrolizumab 1parsaclisib 1palbociclib 1gedatolisib 1duvelisib 1ceralasertib 1capivasertib 1binimetinib 1Trimetazidine 1Paclitaxel 1Oxaliplatin 1Leuprolide 1Leucovorin 1Irinotecan 1Goserelin 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hereditary Sensory and Autonomic Neuropathies × NVP-BKM120 × Clear all
NCT01470209 2018-03-19

A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

Emory University

Phase 1 Completed
43 enrolled
Thoracic

Lung Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT01572727 2017-03-09

BELLE-4

Novartis

Phase 2/3 Completed
416 enrolled 11 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡